Tower Research Capital LLC (Trc) Agios Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 10,286 shares of AGIO stock, worth $342,523. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,286
Previous 3,056
236.58%
Holding current value
$342,523
Previous $135,000
149.63%
% of portfolio
0.01%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding AGIO
# of Institutions
237Shares Held
57.1MCall Options Held
374KPut Options Held
394K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$189 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$188 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$162 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$124 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$80.7 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.83B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...